IRIS
ANSALDI, FILIPPO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 27.693
AS - Asia 2.951
NA - Nord America 1.880
SA - Sud America 282
AF - Africa 48
OC - Oceania 5
Totale 32.859
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 27.152
US - Stati Uniti d'America 1.772
SG - Singapore 1.255
CN - Cina 770
VN - Vietnam 482
FR - Francia 240
BR - Brasile 183
BD - Bangladesh 170
HK - Hong Kong 84
DE - Germania 66
AR - Argentina 55
CA - Canada 52
FI - Finlandia 50
GB - Regno Unito 39
JP - Giappone 30
IQ - Iraq 26
MX - Messico 26
CH - Svizzera 22
ID - Indonesia 21
IN - India 21
NL - Olanda 20
RU - Federazione Russa 14
IE - Irlanda 12
CO - Colombia 11
ES - Italia 11
ZA - Sudafrica 11
PH - Filippine 10
MA - Marocco 9
PK - Pakistan 9
PL - Polonia 9
UA - Ucraina 9
CL - Cile 8
EC - Ecuador 8
SA - Arabia Saudita 8
UZ - Uzbekistan 7
PY - Paraguay 6
SE - Svezia 6
TN - Tunisia 6
TR - Turchia 6
TT - Trinidad e Tobago 6
VE - Venezuela 6
AE - Emirati Arabi Uniti 5
DO - Repubblica Dominicana 5
KE - Kenya 5
LB - Libano 5
MY - Malesia 5
NP - Nepal 5
RO - Romania 5
AU - Australia 4
EG - Egitto 4
GR - Grecia 4
HN - Honduras 4
HR - Croazia 4
OM - Oman 4
AL - Albania 3
AZ - Azerbaigian 3
ET - Etiopia 3
GT - Guatemala 3
HU - Ungheria 3
IL - Israele 3
KR - Corea 3
PT - Portogallo 3
RS - Serbia 3
AT - Austria 2
BE - Belgio 2
BH - Bahrain 2
BO - Bolivia 2
CI - Costa d'Avorio 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
DZ - Algeria 2
GE - Georgia 2
IS - Islanda 2
JM - Giamaica 2
KW - Kuwait 2
LU - Lussemburgo 2
MD - Moldavia 2
MN - Mongolia 2
NI - Nicaragua 2
PA - Panama 2
SV - El Salvador 2
TG - Togo 2
TH - Thailandia 2
AM - Armenia 1
AO - Angola 1
BG - Bulgaria 1
BY - Bielorussia 1
CR - Costa Rica 1
CY - Cipro 1
EE - Estonia 1
GM - Gambi 1
GP - Guadalupe 1
JO - Giordania 1
KG - Kirghizistan 1
KN - Saint Kitts e Nevis 1
KZ - Kazakistan 1
LK - Sri Lanka 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PE - Perù 1
Totale 32.851
Salva come PNG Salva come JPEG
Città #
Genova 15.580
Genoa 6.753
Rapallo 2.510
Vado Ligure 1.787
San Jose 638
Singapore 590
Bordighera 271
Lauterbourg 218
Ashburn 179
Ho Chi Minh City 158
Beijing 133
New York 104
Hanoi 95
Hong Kong 81
Santa Clara 77
Council Bluffs 73
Frankfurt am Main 54
Helsinki 46
Los Angeles 35
Milan 33
Tokyo 26
Da Nang 24
Dallas 24
Tianjin 23
São Paulo 22
Zurich 22
Orem 19
Haiphong 18
Rome 18
Mexico City 17
Buffalo 16
Amsterdam 15
Chicago 12
London 12
Toronto 12
Turin 12
Baghdad 11
Boardman 11
Charlotte 11
Dublin 11
Houston 11
Montreal 11
Phoenix 11
Atlanta 10
Biên Hòa 10
City of London 10
Hải Dương 9
Naples 8
San Francisco 8
Can Tho 7
Palermo 7
Paris 7
Warsaw 7
Bologna 6
Brasília 6
Cardiff 6
Castelluccio dei Sauri 6
Chennai 6
Dhaka 6
Guangzhou 6
Las Vegas 6
Pasadena 6
Quảng Ngãi 6
Rio de Janeiro 6
Brooklyn 5
Denver 5
Florence 5
Jeddah 5
Johannesburg 5
Memphis 5
Nha Trang 5
Piscataway 5
Stockholm 5
Tashkent 5
Thái Nguyên 5
Verona 5
Asunción 4
Buenos Aires 4
Calgary 4
Curitiba 4
Hangzhou 4
Kyiv 4
Lappeenranta 4
Madrid 4
Manaus 4
Miami 4
Nairobi 4
Osasco 4
Parma 4
Phủ Lý 4
Quito 4
Santiago 4
Shanghai 4
Surabaya 4
Addis Ababa 3
Athens 3
Baku 3
Belgrade 3
Belo Horizonte 3
Birmingham 3
Totale 30.083
Salva come PNG Salva come JPEG
Nome #
Adjuvanted seasonal influenza vaccines and perpetual viral metamorphosis: the importance of cross-protection 496
Surveillance of hospital-acquired infections in Liguria, Italy: results from a regional prevalence study in adult and paediatric acute-care hospitals. 260
Fifteen years of epidemiologic, virologic and syndromic influenza surveillance: A focus on type B virus and the effects of vaccine mismatch in Liguria region, Italy 254
Influenza vaccination among healthcare workers in Italy. 248
A new assay for hepatitis C virus (HCV) core antigen detection: an alternative to nucleic acid technologies in positive or indeterminate anti-HCV subjects? 222
Carriage of Streptoccoccus pneumoniae 7 years after implementation of vaccination program in a population with very high and long-lasting coverage, Italy. 219
Epidemiological changes after PCV7 implementation in Italy: perspective for new vaccines. 218
Characteristics of staphylococcus aureus bacteraemia and predictors of early and late mortality 216
Impaired response to influenza vaccine associated with persistent memory B cell depletion in non-Hodgkin's lymphoma patients treated with rituximab-containing regimens. 216
Antigenic characterisation of influenza B virus with a new microneutralisation assay: comparison to haemagglutination and sequence analysis 215
2015/16 seasonal vaccine effectiveness against hospitalisation with influenza a(H1N1)pdm09 and B among elderly people in Europe: Results from the I-MOVE+ project 213
Assessment of knowledge, attitudes, and propensity towards HPV vaccine of young adult students in Italy 213
Adherence to international and national recommendations for the prevention of surgical site infections in Italy: results from an observational prospective study in elective surgery. 209
Vaccine-preventable infections in Systemic Lupus Erythematosus 203
Ras-induced resistance to lapatinib is overcome by MEK inhibition 201
Incidence and outcome of invasive candidiasis in intensive care units (icus) in europe: Results of the eucandicu project 196
Immunization Campaigns and Strategies against Human Papillomavirus in Italy: The Results of a Survey to Regional and Local Health Units Representatives 195
Analysis of a 3-months measles outbreak in western Liguria, Italy: Are hospital safe and healthcare workers reliable? 195
A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality. 194
Synergistic interactions between HDAC and sirtuin inhibitors in human leukemia cells. 188
Effectiveness of pneumococcal vaccines in preventing pneumonia in adults, a systematic review and meta-analyses of observational studies 186
Clinical characteristics and predictors of mortality in cirrhotic patients with candidemia and intra-abdominal candidiasis: a multicenter study 185
Adjuvants and alternative routes of administration towards the development of the ideal influenza vaccine 184
[Immunization campaign with 13-valent Pneumococcal Conjugate Vaccine in adults in Liguria Region, Italy: one year post-introduction preliminary results] 184
A meningococcal carrier survey, in Italy 183
An unexpected Streptococcus pneumoniae strain. 179
[Immunization campaign with 13-valent Pneumococcal Conjugate Vaccine in adults in Liguria Region, Italy: one year post-introduction preliminary results] 177
Global reaction to the recent outbreaks of Zika virus: Insights from a Big Data analysis 176
Inactivated influenza vaccines: recent progress and implications for the elderly 174
A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality 174
Burden of the 1999-2008 seasonal influenza epidemics in Italy: comparison with the H1N1v (A/California/07/09) pandemic. 173
A randomized clinical trial assessing immunogenicity and safety of a double dose of virosomal-adjuvanted influenza vaccine administered to unprimed children aged 6-35 months 170
Seasonal and pandemic (A/H1N1 2009) MF-59-adjuvanted influenza vaccines in complete remission non-Hodgkin lymphoma patients previously treated with rituximab containing regimens. 170
Surgical Prevention of Arm Lymphedema After Breast Cancer Treatment 166
Universal influenza virus vaccines: what needs to happen next? 166
Burden and prevention of hpv. Knowledge, practices and attitude assessment among pre-adolescents and their parents in Italy 166
Antibody response against heterogeneous circulating influenza virus strains elicited by MF59- and non-adjuvanted vaccines during seasons with good or partial matching between vaccine strain and clinical isolates 164
Impatto della pertosse nella popolazione e strategie di prevenzione vaccinale 164
Increasing Incidence of Streptococcus pneumoniae Serotype 19A and Emergence of Two Vaccine Escape Recombinant ST695 Strains in Liguria, Italy, 7 Years after Implementation of the 7-Valent Conjugated Vaccine. 164
The impact of 10-valent and 13-valent pneumococcal conjugate vaccines on hospitalization for pneumonia in children: A systematic review and meta-analysis 163
Neutralizing and Hemagglutination-Inhibiting Activities of Antibodies Elicited by the 2004-2005 Influenza Vaccine against Drifted Viruses. 161
State of the Art, Unresolved Issues, and Future Research Directions in the Fight against Hepatitis C Virus: Perspectives for Screening, Diagnostics of Resistances, and Immunization 161
Molecular characterization of a new variant of rotavirus P[8]G9 predominant in a sentinel-based survey in central Italy 160
Seroprevalence of HTLV-I and HTLV-II infection among immigrants in northern Italy 159
Molecular characterization of influenza B viruses circulating in Northeren Italy during the 2001-2002 epidemic season 157
Burden of rotavirus disease and cost-effectiveness of universal vaccination in the Province of Genoa (Northern Italy) 157
Antiviral activity of amantadine in elderly patients with chronic hepatitis C 157
An outbreak of hepatitis C virus in a haemodialysis unit: molecular evidence of patient-to-patient transmission 156
Different seroprevalence and molecular epidemiology patterns of hepatitis C virus infection in Italy. 156
Carriage of Streptoccoccus pneumoniae in healthy adults aged 60 years or over in a population with very high and long-lasting pneumococcal conjugate vaccine coverage in children: rationale and perspectives for PCV13 implementation. 154
Phase 4 randomized trial of intradermal low-antigen-content inactivated influenza vaccine versus standard-dose intramuscular vaccine in HIV-1-infected adults. 154
Seasonal influenza beginning in Europe: report from EISS. 154
Fluzone® intra-dermal (Intanza® / Istivac® Intra-dermal): An updated overview 153
Epidemiology of viral respiratory tract infections in an outpatient haematology facility 153
An outbreak of influenza in a residential drug-rehabilitation community 152
Direct detection of Bordetella pertussis and Bordetella parapertussis: comparison of polymerase chain reaction and culture. 151
SARS-CoV, influenza A and syncitial respiratory virus resistance against common disinfectants and ultraviolet irradiation 151
Hepatitis C virus in the new era: perspectives in epidemiology, prevention, diagnostics and predictors of response to therapy 151
Risk factors for severe complications of the novel influenza A (H1N1): analysis of patients hospitalized in Italy. 151
Intradermal influenza vaccine and new devices: a promising chance for vaccine improvement 150
Patients Treated with Rituximab-Containing Immunochemotherapy Have a Significant and Prolonged Lack of Humoral Response to Influenza Vaccine Associated with a Persistent Depletion of B Memory Cells 150
Burden of rotavirus associated and non-rotavirus-associated diarrhea among nonhospitalized individuals in central Italy: a 1-year sentinel-based epidemiological and virological surveillance 150
Hepatitis A incidence and hospital-based seroprevalence in Italy: a nation-wide study 150
MOLECULAR AND SEROLOGICAL DIVERSITY OF NEISSERIA MENINGITIDIS CARRIER STRAINS ISOLATED FROM ITALIAN STUDENTS AGED 14-22 YEARS. 149
Vaccinazione antinfluenzale degli operatori sanitari presso l’IRCCS AOU San Martino-IST di Genova: progetto-pilota di counselling e offerta attiva direttamente presso reparti a elevato rischio 149
Immunomodulation due to plasma or plasma-platelet apheresis donation: Events occurring during donation procedures. 148
Clinical and therapeutic aspects of candidemia: A five year single centre study 147
Determinants of invasiveness and ability to cause invasive pneumococcal disease, pneumonia and acute otitis media of different serotypes of Streptococcus pneumoniae. 146
Measles outbreak in Grosseto, central Italy, 2006. 145
Infective endocarditis in elderly: An Italian prospective multi-center observational study 145
Intanza(®) 15 mcg intradermal influenza vaccine elicits cross-reactive antibody responses against heterologous A(H3N2) influenza viruses 145
Repeated seasonal influenza vaccination among elderly in Europe: Effects on laboratory confirmed hospitalised influenza 145
High-dose daptomycin in documented Staphylococcus aureus infections. 145
Influenza and respiratory syncytial virus in infants and children: relationship with attendance at a paediatric emergency unit and characteristics of the circulating strains 144
Pneumococcus and the elderly in Italy: A summary of available evidence regarding carriage, Clinical burden of lower respiratory tract infections and on-field effectiveness of PCV13 vaccination 144
Potential effect of PCV13 introduction on Emergency Department accesses for lower respiratory tract infections in elderly and at risk adults 143
r-IFN alfa-2b/ribavirin combined therapy followed by low dose of IFN alfa 2b in chronic hepatitis C IFN nonresponders 142
Fluzone® Intradermal vaccine: a promising new chance to increase the acceptability of influenza vaccination in adults 142
Ostreopsis ovata and human health: epidemiological and clinical features of respiratory syndrome outbreaks from a two-year syndromic surveillance, 2005-06, in north-west Italy 141
Influenza Burden on Italian Paediatric Population: Five year Nation-wide Surveillance and Correlation between Epidemiological and Virological Data 140
Influenza control in the 21st century: Optimizing protection of older adults 140
Simultaneous Detection of Anti-HCV Antibody and HCV Core Antigen. 140
New A/H3N2 influenza variant: a small genetic evolution but a heavy burden on the Italian population during the 2004-2005 season 140
Sequentialoutbreaks of multidrug-resistant Acinetobacter baumannii in intensive care units of a tertiary referral hospital in Italy: combined molecular approach for epidemiological investigation 140
A possible role of soluble HLA-I molecule in the immunomodulatory effects of therapeutic apheresis. 140
Head-to-head comparison of an intradermal and a virosome influenza vaccine in patients over the age of 60: evaluation of immunogenicity, cross-protection, safety and tolerability. 140
Vaccination recommendations for patients with neuromuscular disease. 140
Bacterial carriage and respiratory tract infections in subjects ≥ 60 years during an influenza season: implications for the epidemiology of Community Acquired Pneumonia and influenza vaccine effectiveness 140
Nosocomial candidemia in patients admitted to medicine wards compared to other wards: a multicentre study 140
Italian health care workers’ knowledge, attitudes, and practices regarding human papillomavirus infection and prevention 140
Silymarin and S-adenosyl-L-methionine (SAMe): two promising pharmacological agents in case of chronic alcoholic hepathopathy. A review and a point of view. 139
Safety and immunogenicity of conventional subunit and MF-59 adjuvanted influenza vaccines in human immunodeficiency virus-1-seropositive patients 139
Universal childhood immunisation against Streptococcus pneumoniae: the five-year experience of Liguria, Italy 139
Pegylated interferon (PEG-IFN) alfa-2b and ribavirin for recurrent hepatitis C (genotype 1) after liver transplantation: relationship with steatosis 138
Is empiric daptomycin effective in reducing mortality in Staphylococcus aureus bacteraemia? A real-life experience 138
Has Clinical and Epidemiological Varicella Burden Changed over Time in Children? Overview on Hospitalizations, Comorbidities and Costs from 2010 to 2017 in Italy 138
Interaction between Helicobacter pylori, diet, and genetic polymorphisms as related to non-cancer diseases 135
Pneumococcal vaccination in Europe: schedule adherence. 135
Latent tuberculosis infection among a large cohort of medical students at a teaching hospital in Italy 135
A novel approach to reduce the hepatitis C virus window period: clinical evaluation of a new ELISA assay for HCV core antigen 134
Totale 16.817
Salva come PNG Salva come JPEG
Categoria #
all - tutte 108.405
article - articoli 96.399
book - libri 0
conference - conferenze 7.532
curatela - curatele 0
other - altro 264
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.210
Totale 216.810
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021156 0 0 0 0 0 0 0 0 0 0 0 156
2021/20222.906 60 171 297 371 84 173 174 769 149 229 107 322
2022/20232.988 299 216 28 293 481 566 27 227 491 31 295 34
2023/20241.660 76 217 29 184 118 239 60 355 104 21 74 183
2024/20254.569 164 337 123 319 560 485 459 701 170 224 436 591
2025/20268.120 940 234 578 587 1.014 791 1.292 371 662 665 460 526
Totale 33.150